Globus Medical, Inc. (NYSE:GMED) Receives $96.91 Average Price Target from Analysts
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1 year price objective […]
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve analysts that are covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1 year price objective […]
